Through important chemistry and the right engineering, there’s new opportunity for CAR T therapeutics to target different forms of cancer with limited toxicity.
- COGs And Biology, Two Endpoints Needlessly At Odds In Advanced Therapy
- The Long Road To U.S. Vaccine Manufacturing
- Compliance, Costs, And Site Readiness In CAR-T Clinical Trials
- All The Ways Global Biopharma Still Grapples With Annex 1
- Managing Operational Challenges In CAR-T Clinical Trial Logistics
- FDA's 483 Playbook: What It Means For Pharma Outsourcing — And What It Doesn't Address
- Organic Impurities: New Draft ICH Q3E Guidance For Leachables And Extractables
- Building Harmonized Real‑World Data In Oncology
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Mold In Cleanrooms: A Persistent Threat And The Case For Proactive Bio-Decontamination
Learn how a comprehensive investigation and systems-level bio-decontamination strategy successfully eliminated persistent mold contamination in a vaccine manufacturing facility's high-risk area.
-
Lightning-Link® Conjugation Kits: Consistent Performance On A Broad Scale
Learn about labeling technology offering a transformative solution through direct antibody labeling without the need for post-conjugation purification, thereby mitigating antibody loss and ensuring reproducible results.
-
Molecular Approaches To Streamline Cell Therapy Product Analytical Testing
Learn how rapid molecular methods of cell therapy testing like qPCR for mycoplasma, sterility, and lentiviral quantification are key to accelerating product release and timely treatment delivery.
-
Optimizing Performance For De-Risked Lentiviral Vector Production
Discover a de-risked, reproducible, and scalable platform for efficient GMP manufacturing of lentiviral vectors that maximizes titers and enriches recovery through upstream and downstream optimization.
-
A Beginner's Guide To Sf9 Culture In Stirred-Tank Bioreactors
Learn about the workflow steps for Sf9 cell expansion, virus preparation, and protein production in stirred-tank bioreactors, including GFP expression.
-
Demonstration Of Scalability For A Novel Fixed Bed Reactor Platform
Designed to enable efficient scalability, a new FBR platform allows operators to use one technology, with a standardized workflow, for their process development, scale-up, and manufacturing processes.
-
Automating Mass Spectrometry Analysis To Accelerate Oligonucleotide Drug Development
Oligonucleotide therapeutics demand precise and efficient analytical workflows. Explore how automated data processing offers a faster path to understanding metabolites and advancing development.
-
Case Study: Full Clonality Assessment Of CHO Cell Line
In this case study, a comprehensive genetic analysis was performed on a transgenic Chinese hamster ovary (CHO) master cell bank to characterize the bank and provide high-confidence evidence of clonality.
-
Bringing Clinical Trials To Everyone's Backyard
Learn how bringing clinical trials to any community around the world is not only possible but also increases patient access and reach and improves recruitment and retention.
-
Accelerating A Global, FIH ADC Therapy Trial For Lung Cancer
Choose a development partner who can navigate global execution, ADC-specific challenges, and Project Optimus requirements so your first-in-human study is designed and positioned for success.
NEWSLETTER ARCHIVE
- 03.20.26 -- Lessons From Bringing A New T Cell Class For Autoimmune Diseases To Clinic
- 03.19.26 -- Your Guide To AAV Success: Characterization, QC, And Viral Clearance Strategies
- 03.19.26 -- Powering AI And Synthetic Biology In Therapy Design
- 03.18.26 -- Advance Your MSC Process: New Research, Expert Talks, And Scaling Solutions
- 03.18.26 -- Proteomics Tools: A Resurrection
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections